Millennium Management LLC Takes Position in LifeVantage Co. (NASDAQ:LFVN)

Millennium Management LLC purchased a new stake in shares of LifeVantage Co. (NASDAQ:LFVN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 32,723 shares of the company's stock, valued at approximately $574,000. Millennium Management LLC owned 0.26% of LifeVantage as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Bank of New York Mellon Corp boosted its position in LifeVantage by 43.9% during the fourth quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company's stock worth $1,300,000 after purchasing an additional 22,620 shares during the period. American Century Companies Inc. lifted its stake in shares of LifeVantage by 50.5% during the 4th quarter. American Century Companies Inc. now owns 95,552 shares of the company's stock valued at $1,675,000 after buying an additional 32,055 shares in the last quarter. Hillsdale Investment Management Inc. boosted its holdings in LifeVantage by 7.3% in the 4th quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company's stock worth $258,000 after buying an additional 1,000 shares during the period. LPL Financial LLC grew its stake in LifeVantage by 301.0% in the 4th quarter. LPL Financial LLC now owns 211,039 shares of the company's stock valued at $3,700,000 after buying an additional 158,405 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC grew its stake in LifeVantage by 56.2% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 93,576 shares of the company's stock valued at $1,640,000 after buying an additional 33,658 shares in the last quarter. Hedge funds and other institutional investors own 35.32% of the company's stock.

LifeVantage Price Performance

Shares of NASDAQ:LFVN traded up $0.22 during trading on Thursday, hitting $12.87. 65,622 shares of the company were exchanged, compared to its average volume of 144,895. LifeVantage Co. has a 52-week low of $5.22 and a 52-week high of $27.38. The stock has a 50 day moving average of $12.90 and a 200 day moving average of $16.18. The company has a market cap of $162.01 million, a PE ratio of 22.98 and a beta of 0.43.

LifeVantage (NASDAQ:LFVN - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.10. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%. The company had revenue of $58.44 million for the quarter, compared to analyst estimates of $60.99 million.

LifeVantage Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be paid a dividend of $0.045 per share. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.18 annualized dividend and a yield of 1.40%. This is a boost from LifeVantage's previous quarterly dividend of $0.04. LifeVantage's payout ratio is currently 26.09%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.